当前位置:首页 - 行情中心 - 仙琚制药(002332) - 财务分析 - 现金流量表

仙琚制药

(002332)

  

流通市值:86.84亿  总市值:87.25亿
流通股本:9.85亿   总股本:9.89亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金710,971,908.643,516,488,366.642,505,196,638.791,696,576,041.96
  收到的税费返还129,640.987,030,355.864,340,908.054,285,265.7
  收到其他与经营活动有关的现金122,175,205.79142,586,780.8272,307,196.3649,004,951.13
  经营活动现金流入小计833,276,755.413,666,105,503.322,581,844,743.21,749,866,258.79
  购买商品、接受劳务支付的现金152,250,012.46889,028,266.22523,816,843.06372,594,898.48
  支付给职工以及为职工支付的现金205,313,693.3738,685,264.13558,262,951.85401,830,500.55
  支付的各项税费77,458,262.44300,993,356.71244,113,020.79167,749,089
  支付其他与经营活动有关的现金263,469,975.571,489,920,611.491,128,140,631.93808,021,756.31
  经营活动现金流出小计698,491,943.773,418,627,498.552,454,333,447.631,750,196,244.34
  经营活动产生的现金流量净额134,784,811.64247,478,004.77127,511,295.57-329,985.55
二、投资活动产生的现金流量:
  取得投资收益收到的现金1,000,0002,205,0002,205,000-
  处置固定资产、无形资产和其他长期资产收回的现金净额909,552.58764,980.22340,201.4123,662.66
  处置子公司及其他营业单位收到的现金净额-10,462,250.55--
  收到的其他与投资活动有关的现金-0--
  投资活动现金流入小计1,909,552.5813,432,230.772,545,201.4123,662.66
  购建固定资产、无形资产和其他长期资产支付的现金43,267,901.7209,073,996.22166,336,311.27136,330,874.27
  投资支付的现金300,000500,000290,909290,909
  支付其他与投资活动有关的现金-0--
  投资活动现金流出小计43,567,901.7209,573,996.22166,627,220.27136,621,783.27
  投资活动产生的现金流量净额-41,658,349.12-196,141,765.45-164,082,018.86-136,598,120.61
三、筹资活动产生的现金流量:
  吸收投资收到的现金-1,350,0001,350,000900,000
  其中:子公司吸收少数股东投资收到的现金-1,350,0001,350,000900,000
  取得借款收到的现金100,000,000414,945,752329,000,000321,500,000
  收到其他与筹资活动有关的现金--6,533,205.136,533,205.13
  筹资活动现金流入小计100,000,000416,295,752336,883,205.13328,933,205.13
  偿还债务支付的现金148,402,749.04270,941,299.26114,804,483.396,385,092.81
  分配股利、利润或偿付利息支付的现金696,904.45401,510,861.48301,318,050.26300,127,420.42
  其中:子公司支付给少数股东的股利、利润--2,000,0002,000,000
  支付其他与筹资活动有关的现金855,127.285,053,918.685,379,487.253,308,865.81
  筹资活动现金流出小计149,954,780.77677,506,079.42421,502,020.9309,821,379.04
  筹资活动产生的现金流量净额-49,954,780.77-261,210,327.42-84,618,815.7719,111,826.09
四、汇率变动对现金及现金等价物的影响-20,621,336.9225,614,564.141,513,544.6342,751,638.38
五、现金及现金等价物净增加额22,550,344.83-184,259,524-79,675,994.43-75,064,641.69
  加:期初现金及现金等价物余额1,191,214,116.751,376,132,147.751,376,132,147.751,376,132,147.75
  期末现金及现金等价物余额1,213,764,461.581,191,872,623.751,296,456,153.321,301,067,506.06
补充资料:
  净利润-452,603,660.56-296,096,657.34
  资产减值准备-45,502,910.2-29,152,050.72
  固定资产和投资性房地产折旧-197,370,878.44-104,519,024.44
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-197,370,878.44-104,519,024.44
  无形资产摊销-20,483,525.48-10,609,292.26
  长期待摊费用摊销-2,789,649.96-1,464,705.57
  处置固定资产、无形资产和其他长期资产的损失--46,299,441.47--46,212,235.3
  固定资产报废损失-1,485,898.98-888,061.12
  财务费用-7,625,804.22-3,724,010.57
  投资损失-26,411,420.79-9,438,418.86
  递延所得税--4,704,151.87--3,512,637.94
  其中:递延所得税资产减少--4,704,151.87--3,512,637.94
  存货的减少--6,400,995.02--54,828,485.2
  经营性应收项目的减少--275,983,458.27--152,345,545.9
  经营性应付项目的增加--178,117,120.96--201,285,441.7
  现金的期末余额-1,191,872,623.75-1,301,067,506.06
  减:现金的期初余额-1,376,132,147.75-1,376,132,147.75
  现金及现金等价物的净增加额--184,259,524--75,064,641.69
公告日期2026-04-282026-04-232025-10-282025-08-27
审计意见(境内)标准无保留意见
TOP↑